BIOPRENE LTD

Company Registration Number:
14915562 (England and Wales)

Unaudited abridged accounts for the year ended 30 June 2024

Period of accounts

Start date: 05 June 2023

End date: 30 June 2024

BIOPRENE LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Company Information - 3
Report of the Directors - 4
Profit and Loss Account - 5
Balance sheet - 6
Additional notes - 8
Balance sheet notes - 11

BIOPRENE LTD

Company Information

for the Period Ended 30 June 2024




Director: Alison Marie Mackay
Registered office: 7
Park Road
Great Sankey
Warrington
Cheshire
WA5 3BY
Company Registration Number: 14915562 (England and Wales)

BIOPRENE LTD

Directors' Report Period Ended 30 June 2024

The directors present their report with the financial statements of the company for the period ended 30 June 2024

Principal Activities

Swimming Teaching

Directors

The directors shown below have held office during the whole of the period from 05 June 2023 to 30 June 2024
Alison Marie Mackay

This report was approved by the board of directors on 24 March 2025
And Signed On Behalf Of The Board By:

Name: Alison Marie Mackay
Status: Director

BIOPRENE LTD

Profit and Loss Account

for the Period Ended 30 June 2024


Notes
13 months to
30 Jun 2024
£
Gross Profit or (Loss) 1,150
Income from coronavirus (COVID-19) business support grants 0
Distribution Costs ( 0 )
Administrative Expenses ( 0 )
Operating Profit or (Loss) 1,150
Interest Receivable and Similar Income 0
Interest Payable and Similar Charges ( 0 )
Profit or (Loss) Before Tax 1,150
Tax on Profit ( 0 )
Profit or (Loss) for Period 1,150

The notes form part of these financial statements

BIOPRENE LTD

Balance sheet

As at 30 June 2024


Notes
13 months to
30 Jun 2024
£
Fixed assets
Intangible assets: 4 0
Tangible assets: 5 0
Total fixed assets: 0
Current assets
Stocks: 0
Debtors: 0
Cash at bank and in hand: 99
Total current assets: 99
Prepayments and accrued income: 0
Creditors: amounts falling due within one year: ( 0 )
Net current assets (liabilities): 99
Total assets less current liabilities: 99
Creditors: amounts falling due after more than one year: ( 0 )
Provision for liabilities: ( 0 )
Accruals and deferred income: ( 0 )
Total net assets (liabilities): 99

The notes form part of these financial statements

BIOPRENE LTD

Balance sheet continued

As at 30 June 2024


Notes
13 months to
30 Jun 2024
£
Capital and reserves
Called up share capital: 99
Revaluation reserve: 6 0
Profit and loss account: 0
Shareholders funds: 99

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 March 2025
And Signed On Behalf Of The Board By:

Name: Alison Marie Mackay
Status: Director

The notes form part of these financial statements

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 2. Employees

    13 months to
    30 Jun 2024
    Average number of employees during the period 1

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 3. Off balance sheet disclosure

    No

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

  • 4. Intangible assets

    Total
    Cost £
    Additions 0
    Disposals (0)
    Revaluations 0
    Transfers 0
    At 30 June 2024 0
    Amortisation
    Charge for year 0
    On disposals (0)
    Other adjustments 0
    Amortisation at 30 June 2024 0
    Net book value
    Net book value at 30 June 2024 0

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

5. Tangible Assets

Total
Cost £
Additions 0
Disposals (0)
Revaluations 0
Transfers 0
At 30 June 2024 0
Depreciation
Charge for year 0
On disposals (0)
Other adjustments 0
At 30 June 2024 0
Net book value
At 30 June 2024 0

BIOPRENE LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

6. Revaluation reserve

13 months to
30 Jun 2024
£
Surplus or deficit after revaluation 0
Balance at 30 June 2024 0